Pasithea TherapeuticsKTTA
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 19 institutions reported holding Pasithea Therapeutics Corp. (KTTA) in their 13F filings, up 8 from Q2 2025. 10 opened new positions and 2 sold out. The largest holders were AdvisorShares Investments LLC ($186K), Citadel Advisors ($48K) and Vanguard Group Inc. ($39K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Pasithea Therapeutics Corp.
- CUSIP
- 70261F202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $189K |
| Exits | 2 | $8K |
All 13F filers, Q2 2025 → Q3 2025: 347,053 shares bought and 35,393 shares sold, net +311,660 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| AdvisorShares Investments LLC | 0.03% | Add +33.1% | 257,696 | $186K |
| Citadel Advisors | 0.00% | Add +43.7% | 67,341 | $48K |
| Vanguard Group Inc. | 0.00% | New | 53,815 | $39K |
| Two Sigma Investments, LP | 0.00% | New | 35,760 | $26K |
| XTX Topco Ltd | 0.00% | New | 34,358 | $25K |
| Renaissance Technologies | 0.00% | New | 30,700 | $22K |
| Geode Capital Management, LLC | 0.00% | New | 25,475 | $18K |
| Jane Street Group, LLC | 0.00% | New | 25,053 | $18K |
| Virtu Financial LLC | 0.00% | New | 25,075 | $18K |
| Two Sigma Securities, LLC | 0.00% | New | 20,846 | $15K |
| UBS Group AG | 0.00% | Reduce -56.4% | 18,381 | $13K |
| HRT Financial LP | 0.00% | New | 10,896 | $7K |
| Hurley Capital, LLC | 0.00% | No change | 3,689 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -3.5% | 1,217 | $891 |
| SBI Securities Co., Ltd. | 0.00% | No change | 1,051 | $769 |
| Citigroup Inc. | 0.00% | New | 443 | $319 |
| JPMorgan Chase & Co. | 0.00% | No change | 150 | $108 |
| Bank of America Corp. | 0.00% | Reduce -6.5% | 58 | $43 |
| Royal Bank of Canada | 0.00% | No change | 250 | $0 |
"% of holder's portfolio" is KTTA's weight in each manager's 13F, not the share of Pasithea Therapeutics Corp. the manager owns.